TriSalus Life Sciences Inc. (NASDAQ: TLSI)
$5.2050
+0.4250 ( +6.88% ) 32.1K
TriSalus Life Sciences Inc is an oncology company integrating standard-of-care treatments and its investigational immunotherapeutic, SD-101, with disruptive Pressure Enabled Drug Delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. TriSalus is a commercial-stage medical device and Phase I clinical-stage pharmaceutical company.
Market Data
Open
$5.2050
Previous close
$4.7800
Volume
32.1K
Market cap
$155.82M
Day range
$4.9250 - $5.2400
52 week range
$3.5000 - $10.4200
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 3/a | Insider transactions | 1 | May 21, 2024 |
| 10-q | Quarterly Reports | 83 | May 15, 2024 |
| 8-k | 8K-related | 15 | May 15, 2024 |
| 8-k | 8K-related | 14 | May 07, 2024 |
| 3 | Insider transactions | 2 | May 07, 2024 |
| 4 | Insider transactions | 1 | May 07, 2024 |
| 8-k | 8K-related | 15 | Apr 30, 2024 |
| 8-k | 8K-related | 15 | Apr 16, 2024 |
| 10-k | Annual reports | 110 | Apr 11, 2024 |
| nt | Quarterly Reports | 1 | Apr 02, 2024 |